Menarche, Pregnancies, and Breastfeeding Do Not Modify Long-Term Prognosis in Multiple Sclerosis

Neurology - United States
doi 10.1212/wnl.0000000000007178
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Menarche Increases Relapse Risk in Pediatric Multiple Sclerosis

Multiple Sclerosis
Neurology
2015English

Long Term Consequences of Arsenical Treatment for Multiple Sclerosis.

BMJ
1983English

Experience With Long-Term Rituximab Use in a Multiple Sclerosis Clinic

Multiple Sclerosis Journal – Experimental, Translational and Clinical
2016English

Long-Term Safety and Real-World Effectiveness of Fingolimod in Relapsing Multiple Sclerosis

Patient Related Outcome Measures
2017English

Long-Term Prognosis in Infantile Eczema

BMJ
1955English

Age at Menarche and Risk of Multiple Sclerosis: Current Progress From Epidemiological Investigations

Frontiers in Immunology
AllergyImmunology
2018English

Long-Term Effects of Fingolimod in Multiple Sclerosis: The Randomized FREEDOMS Extension Trial

Neurology
Neurology
2015English

Cognitive Function in Multiple Sclerosis: A Long-Term Look on the Bright Side

PLoS ONE
Multidisciplinary
2019English

Childhood Body Mass Index and Multiple Sclerosis Risk: A Long-Term Cohort Study

Multiple Sclerosis
Neurology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy